Clinical Trial Update: Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection [Phase 3]

View source ↗

Summary

Phase 3 compassionate-use trial update for nitazoxanide in treating Clostridium difficile infection, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Enterocolitis
• Pseudomembranous Colitis

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Daniel M. Musher MD | Conditions: Clostridium Enterocolitis, Pseudomembranous Colitis | Phase 3 | Status: COMPLETED | Results posted: 2017-12-15